SCHEMBL2909092

SCHEMBL2909092

COc1ccccc1[C@@H](C)Nc1ccc2c(NS(=O)(=O)c3cc(F)c(F)c(F)c3)cccc2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 1/20 0.42
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 2/20 0.39
SLC40A1 Q9NP59 1/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
HCRTR1 O43613 1/20 0.38
AXL P30530 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
MAPK1 P28482 1/20 0.37
KRAS P01116 2/20 0.37
SOS1 Q07889 2/20 0.37
KDM4E B2RXH2 1/20 0.37
SCN1A P35498 2/20 0.36
SCN5A Q14524 2/20 0.36
SCN8A Q9UQD0 2/20 0.36
SCN9A Q15858 1/20 0.36
ACLY P53396 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2907959 0.80 ALOX12 (0.41) MAP2K4MEN1KMT2AALDH1A1SLC40A1
SCHEMBL1615349 0.76 MAP2K4 (0.38) MAP2K4MEN1KMT2AALDH1A1SLC40A1
SCHEMBL3949254 0.75 MAP2K4 (0.43) MAP2K4MEN1KMT2AALDH1A1LMNA
SCHEMBL1616338 0.72 SLC40A1 (0.48) MEN1KMT2AALDH1A1SLC40A1MAPT
SCHEMBL2935932 0.72 TDP1 (0.41) MEN1KMT2AALDH1A1MAPTKRAS
SCHEMBL1616371 0.72 SLC40A1 (0.38) MEN1KMT2AALDH1A1SLC40A1MAPT
SCHEMBL2901475 0.72 L3MBTL1 (0.38) MAP2K4MEN1KMT2AALDH1A1SLC40A1
SCHEMBL2904294 0.71 ALOX12 (0.53) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL1613862 0.71 PDE4A (0.42) MAP2K4ALDH1A1SLC40A1MAPTKEAP1
SCHEMBL2904870 0.70 MEN1 (0.49) MEN1KMT2AALDH1A1SLC40A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825253-B2 2-aminoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2010-11-02 US disclosed
EP-2076495-B1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES HOFFMANN LA ROCHE (CH) 2010-08-18 EP disclosed
US-20080081907-A1 2-AMINOQUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2008-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081907-A1 2-AMINOQUINOLINE DERIVATIVES AR, ADRA2C, RCC2 MAP2K4 3870/4885MEN1 645/4885KMT2A 335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.